Early phase oncology can present a number of complexities. What are some ways that sponsors can reduce complexity and manage these challenges? How can they optimize their supply chain and maintain flexibility in trials for such pivotal early phase studies?
In this panel, you’ll hear from industry experts at the intersection of small sample size trials and cutting-edge clinical software on how they are able to manage through a number of difficult scenarios.
You’ll learn about:
February 25, 2021
11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)